ASRT
Price
$0.65
Change
-$0.02 (-2.99%)
Updated
Jul 3 closing price
Capitalization
91.13M
27 days until earnings call
SNOA
Price
$2.97
Change
+$0.05 (+1.71%)
Updated
Jul 3 closing price
Capitalization
2.39M
Interact to see
Advertisement

ASRT vs SNOA

Header iconASRT vs SNOA Comparison
Open Charts ASRT vs SNOABanner chart's image
Assertio Holdings
Price$0.65
Change-$0.02 (-2.99%)
Volume$125.87K
Capitalization91.13M
Sonoma Pharmaceuticals
Price$2.97
Change+$0.05 (+1.71%)
Volume$23.56K
Capitalization2.39M
ASRT vs SNOA Comparison Chart in %
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. SNOA commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Hold and SNOA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ASRT: $0.65 vs. SNOA: $2.97)
Brand notoriety: ASRT and SNOA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 49% vs. SNOA: 48%
Market capitalization -- ASRT: $91.13M vs. SNOA: $2.39M
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. SNOA’s [@Pharmaceuticals: Other] market capitalization is $2.39M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 4 TA indicator(s) are bullish while SNOA’s TA Score has 6 bullish TA indicator(s).

  • ASRT’s TA Score: 4 bullish, 5 bearish.
  • SNOA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNOA is a better buy in the short-term than ASRT.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а +0.32% price change this week, while SNOA (@Pharmaceuticals: Other) price change was +3.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

SNOA is expected to report earnings on Jun 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASRT($91.1M) has a higher market cap than SNOA($2.39M). SNOA YTD gains are higher at: 10.409 vs. ASRT (-25.037). SNOA has higher annual earnings (EBITDA): -4.27M vs. ASRT (-222.9M). ASRT has more cash in the bank: 73.4M vs. SNOA (2.41M). SNOA has less debt than ASRT: SNOA (385K) vs ASRT (39.7M). ASRT has higher revenues than SNOA: ASRT (152M) vs SNOA (12.3M).
ASRTSNOAASRT / SNOA
Capitalization91.1M2.39M3,810%
EBITDA-222.9M-4.27M5,220%
Gain YTD-25.03710.409-241%
P/E Ratio1.21N/A-
Revenue152M12.3M1,236%
Total Cash73.4M2.41M3,051%
Total Debt39.7M385K10,312%
FUNDAMENTALS RATINGS
ASRT vs SNOA: Fundamental Ratings
ASRT
SNOA
OUTLOOK RATING
1..100
451
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
6358
P/E GROWTH RATING
1..100
9963
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNOA's Valuation (62) in the Pharmaceuticals Other industry is in the same range as ASRT (82) in the Pharmaceuticals Major industry. This means that SNOA’s stock grew similarly to ASRT’s over the last 12 months.

SNOA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that SNOA’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as SNOA (97) in the Pharmaceuticals Other industry. This means that ASRT’s stock grew similarly to SNOA’s over the last 12 months.

SNOA's Price Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as ASRT (63) in the Pharmaceuticals Major industry. This means that SNOA’s stock grew similarly to ASRT’s over the last 12 months.

SNOA's P/E Growth Rating (63) in the Pharmaceuticals Other industry is somewhat better than the same rating for ASRT (99) in the Pharmaceuticals Major industry. This means that SNOA’s stock grew somewhat faster than ASRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTSNOA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOGL57.00N/A
N/A
Kopp Glass, Inc.
CFMOF62.18N/A
N/A
Cofinimmo S.A.
ATGN0.59-0.01
-1.19%
Altigen Communications, Inc.
AZMCF0.71-0.02
-2.92%
Arizona Metals Corp.
BLMIF17.85-1.07
-5.66%
Bank Leumi Le Israel

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and AQST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-3.23%
AQST - ASRT
29%
Poorly correlated
+1.09%
OGI - ASRT
28%
Poorly correlated
+3.62%
TLRY - ASRT
27%
Poorly correlated
+11.03%
INDV - ASRT
26%
Poorly correlated
+0.06%
SNOA - ASRT
25%
Poorly correlated
+1.71%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
+1.71%
BNXTF - SNOA
29%
Poorly correlated
+3.55%
BGLAF - SNOA
27%
Poorly correlated
N/A
OGI - SNOA
25%
Poorly correlated
+3.62%
AKAN - SNOA
25%
Poorly correlated
+5.38%
ASRT - SNOA
25%
Poorly correlated
-3.23%
More